Business Description
Elekta AB
ISIN : US28617Y1010
Share Class Description:
EKTAY: ADRCompare
Compare
Traded in other countries / regions
EKTA B.Sweden0O5H.UKEKTAB.MexicoEKTAF.USAEJXB.Germany IPO Date
2008-12-08Description
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.33 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 2.28 | |||||
| Interest Coverage | 6.56 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.71 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.9 | |||||
| 3-Year EBITDA Growth Rate | -5.5 | |||||
| 3-Year EPS without NRI Growth Rate | -4.5 | |||||
| 3-Year FCF Growth Rate | 16.6 | |||||
| 3-Year Book Growth Rate | 6.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 14.63 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.33 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.24 | |||||
| 9-Day RSI | 43.68 | |||||
| 14-Day RSI | 42.9 | |||||
| 6-1 Month Momentum % | 8.82 | |||||
| 12-1 Month Momentum % | -10.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.09 | |||||
| Quick Ratio | 0.82 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 112.52 | |||||
| Days Sales Outstanding | 83.88 | |||||
| Days Payable | 52.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.24 | |||||
| Dividend Payout Ratio | 0.6 | |||||
| 3-Year Dividend Growth Rate | 10.1 | |||||
| Forward Dividend Yield % | 3.24 | |||||
| 5-Year Yield-on-Cost % | 6.66 | |||||
| Shareholder Yield % | -0.88 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.75 | |||||
| Operating Margin % | 13.58 | |||||
| Net Margin % | 7.87 | |||||
| FCF Margin % | 8.5 | |||||
| ROE % | 14.28 | |||||
| ROA % | 4.75 | |||||
| ROIC % | 7.14 | |||||
| ROC (Joel Greenblatt) % | 108.62 | |||||
| ROCE % | 11.92 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.44 | |||||
| Forward PE Ratio | 15.17 | |||||
| PE Ratio without NRI | 18.7 | |||||
| Shiller PE Ratio | 25.63 | |||||
| Price-to-Owner-Earnings | 15.81 | |||||
| PS Ratio | 1.61 | |||||
| PB Ratio | 2.86 | |||||
| Price-to-Free-Cash-Flow | 19.28 | |||||
| Price-to-Operating-Cash-Flow | 9.32 | |||||
| EV-to-EBIT | 16.01 | |||||
| EV-to-Forward-EBIT | 11.52 | |||||
| EV-to-EBITDA | 10.39 | |||||
| EV-to-Forward-EBITDA | 8.21 | |||||
| EV-to-Revenue | 1.78 | |||||
| EV-to-Forward-Revenue | 1.71 | |||||
| EV-to-FCF | 21.88 | |||||
| Price-to-Projected-FCF | 1.78 | |||||
| Price-to-Median-PS-Value | 0.57 | |||||
| Earnings Yield (Greenblatt) % | 6.25 | |||||
| FCF Yield % | 5.55 | |||||
| Forward Rate of Return (Yacktman) % | 2.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EKTAY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Elekta AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,726.848 | ||
| EPS (TTM) ($) | 0.356 | ||
| Beta | 1.2 | ||
| Volatility % | 28.59 | ||
| 14-Day RSI | 42.9 | ||
| 14-Day ATR ($) | 0.150705 | ||
| 20-Day SMA ($) | 7.3342 | ||
| 12-1 Month Momentum % | -10.04 | ||
| 52-Week Range ($) | 6.52 - 8.65 | ||
| Shares Outstanding (Mil) | 382.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Elekta AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Elekta AB Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Elekta AB Frequently Asked Questions
What is Elekta AB(EKTAY)'s stock price today?
The current price of EKTAY is $6.92. The 52 week high of EKTAY is $8.65 and 52 week low is $6.52.
When is next earnings date of Elekta AB(EKTAY)?
The next earnings date of Elekta AB(EKTAY) is 2024-06-05.
Does Elekta AB(EKTAY) pay dividends? If so, how much?
The Dividend Yield %  of Elekta AB(EKTAY) is 3.24% (As of Today), Highest Dividend Payout Ratio of Elekta AB(EKTAY) was 1.03. The lowest was 0.27. And the median was 0.45. The  Forward Dividend Yield % of Elekta AB(EKTAY) is 3.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers